P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)

Market Cap	85.92B
Revenue (ttm)	20.12B
Net Income (ttm)	6.86B
Shares Out	28.88M
EPS (ttm)	237.44
PE Ratio	12.53
Forward PE	n/a
Dividend	40.00 (1.32%)
Ex-Dividend Date	Dec 27, 2024

Volume	3,074
Average Volume	214,297
Open	2,980.00
Previous Close	2,980.00
Day's Range	2,975.00 - 2,985.00
52-Week Range	1,907.00 - 3,300.00
Beta	0.77
RSI	56.43
Earnings Date	Aug 14, 2025

About MorphoSys AG

P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vitro clinical tests. It also manufactures and sells raw pharmaceutical and cosmetic materials, and raw materials for health foods. The company was founded i...

• Industry: Commercial Physical and Biological Research
• Founded: 2010
• Employees: 92
• Stock Exchange: KOSDAQ
• Ticker Symbol: 347740

Financial Performance

In 2024, P&K Skin Research Center's revenue was 17.85 billion, an increase of 20.24% compared to the previous year's 14.84 billion. Earnings were 5.82 billion, an increase of 20.84%.